Description
Y90 RESIN MICROSPHERES
First action · last action
2022-12-19 · 2024-03-04
Transactions
2
First transaction's obligation
$195,250
Base + all options value (sum of deltas)
$17,415
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-12-19+$195,250= $195,250
- Mod P000012024-03-04-$177,835= $17,415
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-12-19 | +$195,250 | $195,250 | Y90 RESIN MICROSPHERES |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2024-03-04 | −$177,835 | $17,415 | Y90 RESIN MICROSPHERES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CWH2GM13A2V6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0384 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $245,194 | FY2026 |
| 36C24826P1090 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $45,825 | FY2026 |
| 36C24826P0903 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $47,962 | FY2026 |
| 36C25926N0187 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $203,300 | FY2026 |
| 36C26226N0179 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $202,940 | FY2026 |
| 36C26226N0180 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $200,940 | FY2026 |
Other recipients under 6505 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826F0207 | CSL BEHRING L.L.C. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $183,903 | FY2026 |
| 36C24826P1108 | ASD SPECIALTY HEALTHCARE, LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $54,600 | FY2026 |
| 36C24826N0511 | BIOMERIEUX INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $61,788 | FY2026 |
| 36C24826N0693 | MEDI-PHYSICS, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $111,150 | FY2026 |
| 36C24826D0041 | PROFOUNDA INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24823P0383_3600_-NONE-_-NONE- · retrieved 2026-09-26.